Speaker: Thomas J. Herzog, MD. Dr. Herzog is Deputy Director of both The Barrett Cancer Center & The University of Cincinnati Cancer Institute. He is also Vice-Chair of Quality and Safety for Obstetrics and Gynecology, University of Cincinnati College of Medicine. From 2004 to 2014 he was the Director of Gynecologic Oncology and the Physicians & Surgeons Endowed Professor of Clinical Gynecology and Obstetrics at Columbia University. He also was the Fellowship Director in Gynecologic Oncology for Columbia & Cornell Universities and New York Presbyterian hospitals.
Prior to 2004, Dr. Herzog was as an Associate Professor, and the Director of the Fellowship Training Program at Washington University in St. Louis. He has served as a Principal Investigator in a number of GOG trials with a special emphasis in ovarian and endometrial cancers.
Dr. Herzog has authored/co-authored over 270 peer-reviewed articles and lectures extensively nationally and internationally. He serves or has served on the editorial boards of Gynecologic Oncology, Obstetrics and Gynecology International, Hematology Oncology Times, and others. He is Co-Editor–in chief of Gynecologic Oncology Research to Practice. Dr. Herzog has been on the leadership council of the Society of Gynecologic Oncology, the Foundation for Women’s Cancer, Board of Governors for the American College of Surgeons. In 2013, he was elected to the Board of the American Board of Obstetrics and Gynecology, and in 2014 to Council for the International Gynecologic Cancer Society. In 2015 he was elected to the Board of Director of Gynecologic Oncology Group Foundation.
- The latest info on the development of drugs for advanced ovarian cancer
- Other novel chemotherapeutic agents in development
- Advances in immunotherapy
- PARP Inhibitors
- The role of molecular profiling
- Info from the Cancer Institute Survivorship Survey
- What do patients want?
Audio and slides from Support Connection’s Ovarian Cancer Webinar – Recorded on Sept. 19, 2017